An Overview on Common Viral Infections in Kidney Transplant Recipients
International Journal of Advances in Nephrology Research,
The viral infections post transplantation are extremely important and guides us about the intensity of immunosuppressant and there monitoring guides us to fine tune the immunosuppression. Similarly the knowledge of the viral diseases post transplantation guides the transplant clinician to diagnose these diseases early and manage them before they become progressive.
Similarly blood transmitted diseases are much more common in resource poor countries. With lack of deceased donor program and paired kidney exchange in infancy we end up doing sensitised or ABO incompatible living donor transplants subjecting them to intense immunosuppressive regimens, which ultimately lead to the emergence of opportunistic viral infections such as CMV, BK and EBV.
- Viral infections
- kidney transplant
- donor transplants
How to Cite
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation Camille N. Kotton, MD, Transplantation 2018; 102: 900– 931.
Perspectives in the Treatment and Prophylaxis of Cytomegalovirus Disease in Solid-Organ Transplant Recipients David R. Snydman, Gilberto Torres-Madriz, Helen W. Boucher Clinical Infectious Diseases. 2008;47(5):702–711.
Approach to Drug-Resistant Cytomegalovirus in Transplant Recipients,Sunwen Chou Curr Opin Infect Dis. 2015; 28(4): 293–299.
Diagnosis of PTLD in solid organ Tx recipients – BCSH and BTS Guidelines Anne Parker, 1(BCSH Lead) Kristin Bowles (BTS Lead) Writing group: On behalf of the Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society
Management of PTLD in solid organ transplant recipients – BCSH and BTS Guidelines Anne Parker,1 (BCSH Lead ) (BTS Lead) Writing group: On behalf of the Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society.
Primary CNS (PTLD): An International Report of 84 Cases in the Modern Era A. M. Evens1,*,y , S. Choquet2,y American Journal of Transplantation 2013;13:1512–1522 Wiley Periodicals.
Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies Uta Erdbruegger, Irina Scheffner, Michael Mengel, Anke Schwarz, Willem Verhagen, Hermann Haller, Wilfried Gwinner Nephrology Dialysis Transplantation. 2012;27(1):435–443.
Effect of Low-Dose Vs Standard-Dose Valganciclovir in the Prevention of Cytomegalovirus Disease in Kidney Transplantation Recipients: A Systemic Re... - PubMed – NCBI
Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients. - PubMed - NCBI Transplantation. 2015;99(7):1499-505.
Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and re... - PubMed - NCBI Transplant Infect Dis. 2016;18(6):904-912.
DOI: 10.1111/tid.12609. Epub 2016 Nov 7. Comparative Study; Multicenter Study
Stevens DR, Sawinski D, Blumberg E, Galanakis N, Bloom RD, Trofe‐Clark J. Increased risk of breakthrough infection among cytomegalovirus donor‐positive /recipient‐negative kidney trans‐ plant recipients receiving lower‐dose valganciclovir prophylaxis. Transplant Infect Dis. 2015;17(2):163‐173.
Abstract View: 82 times
PDF Download: 22 times